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Abstract
Background: There is considerable variation in mortality rates from myocardial infarction
(MI) across high-income countries, some of which may be artefactual.
Methods: Time trends in mortality rates from ischaemic heart disease (IHD) and MI were
analysed for a set of high-income countries from the end of the 1970s. Using individual-
level mortality data from Russia (2005–2017) and Norway (2005–2016), we investigated
factors associated with the proportion of total IHD deaths certified as due to MI.
Results: In most countries, MI mortality rates have dramatically declined from the 1970s.
However, the share of MI in total IHD deaths varies substantially across countries. In
Russia, only 12% of IHD deaths had MI assigned as the underlying cause vs 63% in
Norway. IHD deaths occurring outside of hospital without autopsy were far less likely to
be assigned as MI in Russia (2%) than in Norway (59%).
Conclusions: Although established international criteria for MI require specific clinical or
post-mortem evidence, it appears that certifying specialists in different countries may in-
terpret these criteria differently. At one extreme, Russian doctors may only assign MI as
a cause of death when there is specific pathophysiological evidence. At the other ex-
treme, their counterparts in Norway may be willing to specify MI as the cause even when
this evidence is not available. Internationally established criteria for MI diagnosis are
challenging to apply for out-of-hospital deaths. Differences between countries in how
certifiers interpret these criteria may account for at least some of the international varia-
tion in MI mortality rates.
VC The Author(s) 2021. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Introduction
Understanding the nature of between- and within-country
variation in mortality from cardiovascular diseases (CVDs)
is crucial for promoting better cardiovascular health.
Much of the between-country differences will be explained
by differences in exposure to risk factors and medical care.
However, as has been well documented, within the overall
class of CVD deaths, differences in the certification and
coding of deaths almost certainly make a contribution to
international variation.1–9
Cardiovascular mortality rates in Russia have been
among the highest in the world for many decades and re-
main so despite the declines that have occurred since the
mid-2000s.10,11 The exceptionally high rates in Russia to-
gether with its large population mean that Russia makes a
substantial regional contribution to CVD mortality.
Within the World Health Organization (WHO) European
region in 2019, Russia accounted for almost a quarter
(23%) of all deaths assigned to ischaemic heart disease
(IHD) as the underlying cause.12 However, there have been
very few studies2,9 of the international comparability of
cardiovascular mortality rates that have included Russia.
Myocardial infarction (MI) is an important component
of IHD mortality, information on which is reported by
high-income countries as part of their routine mortality
statistics. These data are used by researchers and policy
makers looking at within-country differences and trends,13
particularly in the context of the impact of hospital admis-
sion.14 A number of studies have looked at the within-
country validity of MI as a cause of death. These have been
reviewed by McCormick et al.,15 who concluded that
researchers should avoid using vital-statistics data on
deaths from MI if hospitalization data are not available to
confirm the cause of death. However, of the studies
reviewed, only five looked at routine cause-of-death data,
and these only covered deaths in the period 1984–1993.
However, little work has been done to consider the degree
to which variation in MI mortality rates between high-
income countries may be driven by artefacts of certification
and coding.
The WHO and professional societies of cardiology have
attempted to standardize the definition of MI, which has
led to increasingly well-defined objectively measured clini-
cal criteria.16–21 The most recent guidelines lay out spe-
cific, largely pathophysiological criteria for establishing a
death from MI.21 How far these criteria have been adopted
by certifying experts in different countries is unknown.
This study was originally motivated by our observation
of an apparent paradox in patterns of mortality rates from
IHD overall and MI in Russia. Although Russia has had
one of the highest IHD mortality rates among industrial-
ized countries, it has one of the lowest reported and stable
rates of mortality from MI.22,23
In this paper, we report the results of an investigation of
how far the low rates of mortality from MI in Russia com-
pared with other countries could be explained by differen-
ces in how the certification of MI as the underlying cause
may be influenced by the place of death and the likelihood
of an autopsy being performed. Although cardiovascular
epidemiologists are aware of the challenge of interpreting
Key Messages
• There are considerable international differences in population-level rates of mortality from myocardial infarction (MI).
Some of this variation may be explained by differences between countries in the minimal criteria required by
certifying doctors to specify MI as the underlying cause of death.
• At one extreme, in Russia there is a tendency for certifiers to ascribe MI as the underlying cause only in contexts in
which pathophysiological evidence is likely to be available, which in most cases will be if the death occurs in hospital
and/or post-mortem autopsy is performed. In contrast at the other extreme, in Norway certifying doctors appear
more willing to specify MI as the underlying cause even for deaths occurring at home in the absence of
pathophysiological evidence. Further research is warranted looking in detail at other countries.
• Despite the considerable efforts of expert groups in developing formal criteria for determining whether a death could
be classified as due to an MI, we have identified evidence of substantial differences in routine certification practice
that mean that these data may not be meaningfully comparable across countries.
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routine cause-of-death data,3,4,6,7,9,15 the potential role of
artefact in explaining differences between countries in MI
mortality within the larger group of all IHD deaths has not
been previously investigated.
Data and methods
We used routine mortality data for Russia, Norway and a
number of other comparator countries representing differ-
ent geopolitical regions (Australia, Czechia, Estonia,
France, Japan, the UK and the USA) to explore the patterns
and structure of IHD mortality between countries. We
then examined how individual-level factors recorded on
the death certificate influence whether an IHD death was
classified as being due to MI in Russia compared with
Norway.
Population-level analysis
For countries except Russia, we used data on deaths by
age, sex and cause from the WHO Mortality Database24
and population exposures from the Human Mortality
Database.25 For Russia, death rates were obtained from
the Russian Fertility and Mortality Database for the whole
available period of 1965–2017.26,27 We divided all cardio-
vascular diseases into three groups: (i) MI (ICD-9 codes:
410; ICD-10 codes: I21, I22), (ii) the rest of the IHDs
(ICD-9 codes: 411–414; ICD-10 codes: I20, I23–I25), (iii)
the rest of the CVDs (ICD-9 codes: 390–409, 415–459;
ICD-10 codes: I00–I19, I26–I99).
We used the European Population Standard (1976) to
calculate age-standardized death rates for the adult popu-
lation (ages 30þ years).28
Individual-level analysis
Anonymized individual-level data on all IHD deaths in Russia
(2005–2017) were obtained from the Russian State Statistical
Service (Rosstat). Equivalent data for Norway (2005–2016)
were provided by the Norwegian Institute of Public Health
(NIPH). These two countries, which share a common border,
report the lowest and highest proportion of MI deaths among
all IHD deaths, respectively. Moreover, they have been the
subject of international comparative studies looking at deter-
minants of differences in CVD risk between them.29–31
Although we wanted to include other countries in this part of
our analysis, attempts to obtain equivalent micro-level data
for other countries were unsuccessful.
Multiple logistic regression was used to estimate the ef-
fect of individual-level factors on the odds of an IHD death
being certified as being due to MI vs the rest of the IHDs.
The dependent variables were sex, age (10-year age groups:
30–39, . . ., 80þ), urban/rural residence, year of death, au-
topsy (yes/no) and place of death (hospital/elsewhere). The
two latter variables are specified on death certificates and
indicate the likelihood of pathophysiological evidence of
an MI being available.
Results
Figure 1 shows time trends of mortality rates from MI, the
rest of the IHDs and the rest of the CVDs by country. MI
mortality rates in all countries in Figure 1 other than
Russia and Estonia (another post-Soviet country) declined
from the 1970s. Some of the falls were particularly steep,
resulting in a convergence in MI rates between countries.
In Russia, the rate of MI mortality was lower than in most
of the comparator countries until the mid-2000s, but at a
similar level to Estonia and Japan in contrast to the rest of
IHDs, for which Russia had the highest rate throughout.
Although the rates for MI remained relatively stable and
low in Russia, mortality rates from the rest of the IHDs and
the rest of the CVDs have been subject to substantial fluctu-
ations particularly among men (Supplementary Figure S1,
available as Supplementary data at IJE online, for more
details). In Russia in 2005, IHD mortality (excluding MI)
entered a phase of sustained decline, but it was only in 2010
that mortality rates from MI began to decrease. These trends
contrast sharply with those seen in all other countries stud-
ied (apart from Estonia), which did not show major fluctua-
tions in mortality rates for the rest of the IHDs (Figure 1).
Unlike the absolute rates of MI mortality, the propor-
tional contribution of MI to overall IHD mortality has not
shown much convergence and still shows appreciable inter-
national variation, with Russia having the lowest and
Norway having the highest proportion of IHD deaths
accounted for by MI (Figure 1, lower panel). Of the other
countries, Estonia exhibits trends that were similar to
Russia, whereas Norway is at the opposite extreme, show-
ing the highest and almost unchanged proportion of IHD
deaths certified as being due to MI. Much of the decline in
MI in Russia since 2010 is accounted for by a fall in rates
for deaths occurring in hospital (27% and 30% for males
and females, respectively) whereas death rates among those
dying out of hospital have changed very little. In contrast,
the substantial decline in mortality rates from the rest of
the IHDs has been mostly driven by a fall in mortality
among those who died at home (38% and 41% for males
and females, respectively).
Using individual-level data, we turn to looking at the in-
fluence of the place of death and whether an autopsy was
conducted on the probability of an IHD death being certi-
fied as being due to MI for Russia and Norway. Overall,
81% of IHD deaths occurred outside of hospital, the
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equivalent figure for Norway being 89%. Table 1 shows
the number and proportion of overall IHD deaths
accounted for by MI according to age, place of death and
autopsy status in the two countries. In Russia, the highest
proportion of IHD deaths assigned to MI are among those
dying in hospital and who had an autopsy (44%) whereas
those who died outside of hospital and did not have an au-
topsy had the lowest proportion assigned to MI (2%).
Norway showed an even higher proportion of IHD deaths
assigned to MI among those who died in hospital and had
an autopsy (60%). However, in Norway, there was also a
high proportion of MI deaths among those dying out of
hospital without an autopsy (59%). The contrast between
the two countries for deaths outside of hospital without an
autopsy is particularly dramatic among those aged
80þ years. At this older age, MI constituted <1% of IHD
in Russia and 56% of IHD in Norway (Table 1).
Table 2 shows the odds ratios (ORs) for having MI speci-
fied as the underlying cause among all IHD deaths accord-
ing to the place of death (hospital/elsewhere) and whether
an autopsy of any type was conducted (yes/no). In Russia,
the OR for having MI as an underlying cause among all
IHD deaths was 46 for deaths in hospital that were autop-
sied relative to those occurring outside of hospital without
an autopsy. There was a progressive decline in OR across
the other categories. However, in Norway, the place of
death and having an autopsy showed far weaker associa-
tions with whether an IHD death was assigned to MI or
not. More detailed results from this analysis are presented in
Supplementary Table S1 (available as Supplementary data
at IJE online).
One feature of IHD deaths in Russia compared with
many other countries is that a much greater proportion of
them are assigned to I25.0 and I25.1. In order to try and
Figure 1 Age-standardized death rates (per 100 000) for (A) myocardial infarction (MI), (B) the rest of the ischaemic heart diseases (IHDs) and (C) the
share of MI in IHD (in %) by sex and countries, since the introduction of ICD-9
Source: Russian Fertility and Mortality Database for Russia; World Health Organization (WHO) Mortality Database for reference countries.






/ije/advance-article/doi/10.1093/ije/dyab188/6368657 by London School of H
ygiene & Tropical M
edicine user on 07 D
ecem
ber 2021
make the category of non-IHD deaths more comparable
with those in Norway, we repeated the analyses presented
in Table 2 having excluded I25.0 and I25.1. As shown in
Supplementary Table S2 (available as Supplementary data
at IJE online), although the Russian ORs were slightly at-
tenuated, very strong associations with place of death and
autopsy remained.
In the final part of our analyses, we considered how far
changes in where deaths occurred in Russia and Norway
might explain patterns of MI mortality. In Russia since
2000, there has been a steep decline in the percentage of
deaths that occurred outside of hospital and did not have
an autopsy. This is apparent for all three classes of CVD
(Figure 2, upper panel). The decline is steepest for IHD in
particular at ages 70þ years and in the most recent years.
MI showed the lowest percentage of deaths occurring out-
side of hospital without an autopsy: 20% in 2000 falling
to 2% in 2017. Put the other way around, the proportion
of CVD deaths occurring in hospital or with an autopsy
has increased substantially over time in Russia, especially
at older ages. In the case of MI, the share of such deaths
constituted 98% in 2017 with almost no variation by age
and sex. In Norway, on the contrary, the share of deaths
that occurred outside of hospital with no autopsy have
been relatively stable over time and across CVD categories
(Figure 2, lower panel). On average, 51%, 54% and 59%
Table 2 Adjusteda odds ratios (95% CIs) for having myocardial infarction (MI) specified as the underlying cause among all deaths
from ischaemic heart disease (IHD) in Russia and Norway
Russia (2005–2017) Norway (2005–2016)
Odds ratio (95% CI) Number of deaths Odds ratio (95%
CI)
Number of deaths
MI Rest of IHD MI Rest of IHD
Deaths in hospital, autopsy 46.49 (46.02–46.96) 382 768 490 767 0.90 (0.84–0.97) 1959 1294
Deaths in hospital, no autopsy 28.84 (26.54–27.14) 133 969 303 803 2.08 (2.00–2.17) 14 802 4884
Deaths out of hospital, autopsy 6.11 (6.05–6.17) 251 619 2 281 886 0.30 (0.27–0.32) 1275 2095
Deaths out of hospital, no autopsy 1.00 [ref] 49 173 3 119 228 1.00 [ref] 19 521 13 381
Source: Estimated from anonymized individual-level data provided by Rosstat and the Norwegian Institute of Public Health (NIPH) upon request.
aAdjusted for sex, age, year and place of residence. CI, confidence interval.
Table 1 Distribution of myocardial infarction (MI) and the rest of the ischaemic heart disease (IHD) deaths by age, place of death
and autopsy in Russia (2005–2017) and Norway (2005–2016)
Deaths in hospital Deaths out of hospital Total deaths
Ages
(years)






















30–49 17 20 46.4% 3 4 43.4% 26 226 10.3% 3 27 9.4% 49 277 15.0%
50–59 52 55 48.3% 12 19 39.8% 56 461 10.8% 7 123 5.5% 127 658 16.2%
60–69 90 100 47.3% 27 50 34.9% 62 502 11.0% 11 400 2.6% 189 1052 15.3%
70–79 133 161 45.3% 53 115 31.6% 62 527 10.5% 17 1158 1.4% 265 1962 11.9%
80þ 91 154 37.0% 39 116 25.0% 46 563 7.6% 11 1412 0.8% 187 2245 7.7%
All ages 383 490 43.8% 134 304 30.6% 252 2279 9.9% 49 3119 1.6% 817 6192 11.7%
Norway
30–49 107 57 65.2% 198 244 44.8% 165 27 85.9% 259 48 84.4% 729 376 66.0%
50–59 217 107 67.0% 334 500 40.0% 434 116 78.9% 793 241 76.7% 1778 964 64.8%
60–69 390 230 62.9% 424 729 36.8% 1118 426 72.4% 1924 732 72.4% 3856 2117 64.6%
70–79 584 394 59.7% 235 410 36.4% 2854 1176 70.8% 3462 1860 65.1% 7135 3840 65.0%
80þ 661 506 56.6% 84 212 28.4% 10 231 3139 76.5% 13 083 10 500 55.5% 24 059 14 357 62.6%
All ages 1959 1294 60.2% 1275 2095 37.8% 14 802 4884 75.2% 19 521 13 381 59.3% 37 557 21 654 63.4%
Source: Estimated from micro-level mortality data provided by Rosstat and the Norwegian Institute of Public Health (NIPH) upon request.
aThe number of deaths in Russia are in thousands.
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of MI, IHD and CVD deaths, respectively, occurred in out-
of-hospital settings without subsequent post-mortem ex-
amination in Norway in 2005–2016.
Discussion
Compared with Norway, and most other countries that we
have examined, MI mortality rates in Russia have been
low and stable. In contrast, IHD mortality rates in Russia
have been the highest. In Russia (2005–2017), only 12%
of IHD deaths had MI assigned as the underlying cause.
This was the lowest proportion of all countries, with
Norway having the highest at 63% (2005–2016). Most im-
portantly, we have found that in Russia, the place of death
and whether an autopsy was conducted were strongly re-
lated to the share of IHD deaths accounted for by MI,
whereas in Norway, these factors had a far weaker
influence. IHD deaths occurring outside of hospital with-
out autopsy were far less likely to be assigned to MI in
Russia (2%) than in Norway (59%). We suggest that these
large contrasts between Russia and Norway may be best
explained by differences in how certifying doctors apply
the international criteria to certify a presumptive death
from IHD as being due to MI.
Up until the 2000s, the definition of MI was based on
the so-called epidemiological approach (primarily electro-
cardiography-based).21 MI would be diagnosed if the fol-
lowing clinical features and their combinations were
present: corresponding ECG changes, typical symptoms of
acute ischaemia and elevated enzymes. Added to this, a di-
agnosis of a fatal case in the absence of these clinical char-
acteristics observed in life required the naked-eye
appearance of a fresh infarction and/or recent coronary oc-
clusion found at autopsy.16 The most recent guidelines
Figure 2 Age-specific percentages of myocardial infarction (MI), ischaemic heart disease (IHD) and cardiovascular disease (CVD) deaths that occurred
outside of hospital without an autopsy, by year of death, Russia(2000–2017) and Norway (2005–2016)
Source: Calculated from micro-level mortality data provided by Rosstat and the Norwegian Institute of Public Health (NIPH) upon request.
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specify that the fundamental criteria for establishing a
death from MI is the detection of abnormal cardiac bio-
markers (e.g. troponin) in the setting of evidence of acute
myocardial ischaemia (suggestive symptoms or new
ischaemic ECG changes) and/or post-mortem evidence of
a fresh thrombus occluding a coronary artery with recent
myocardial damage.21 Previous work has shown that
changes in these sorts of criteria can have a substantial ef-
fect on the rates of incident and prevalent MI.32
We suggest that, in Russia, doctors may be particularly
reluctant to certify a death as being due to acute MI with-
out there being the sort of specific pathophysiological evi-
dence discussed in the previous paragraph. Such evidence
will not usually be available for sudden deaths occurring
outside of hospital, particularly those that are not subject
to autopsy. In contrast, it appears that doctors in Norway
may be more willing to certify deaths as due to MI based
only on reported symptoms and prior clinical history.
What is notable is that Estonia, which was part of the
Soviet Union until the early 1990s, also has a particularly
low proportion of IHD deaths classified as due to MI even
in recent years. This may suggest that any distinctive certi-
fication practices established in the Soviet period have
persisted.
The impact of the correct but conservative approach to
certifying MI deaths in Russia will inevitably lead to an un-
derestimate of the true rate of MI mortality overall, as only
20% of IHD deaths in Russia occur in hospital; the vast
majority happen at home. In contrast, in Norway, those
dying at home are only a little less likely to have MI
assigned as the underlying cause of death compared with
those dying in hospital. This could reflect the fact that
Norwegian certifiers are willing to certify a death as such
even in the absence of direct evidence such as ECG and se-
rum troponin levels and/or the presence of a thrombus or
recent myocardial injury at an autopsy. Notably, Norway
has one of the highest proportions of IHD deaths certified
as being due to MI of any of the comparator countries that
we have looked at.
One of the unusual features of IHD mortality in Russia
is that it has shown very sharp fluctuations in mortality
since the mid-1980s. This has been attributed to simulta-
neous fluctuations in harmful alcohol consumption.33
However, as noted originally by Zaridze et al.,23 mortality
rates from MI in Russia have shown almost no association
with harmful alcohol consumption. Our conclusion that
the true-positive rate of MI deaths in Russia is likely to be
high is consistent with the notion that although classic
atherosclerotic-related MI may not be related to alcohol,
there is an important fraction of deaths attributed to non-
MI IHD that are associated with alcohol. As we have al-
ready noted, compared with other countries, Russia uses
ICD codes I25.0 and I25.1 frequently as an underlying
cause of death, despite the view that they may be garbage
causes that should not be used on death certificates.34
However, our conclusions in this paper concerning the
very strong association of the place of death and autopsy
with an IHD death being assigned to MI was found even
when deaths from I25.0 and I25.1 were excluded from our
analysis of individual-level data (Supplementary Table S2,
available as Supplementary data at IJE online). This sug-
gests that our results are not driven by the inflation of non-
IHD deaths with the opaque category of deaths coded to
I25.0 and I25.1.
In summary, our analysis suggests that Russia is an ex-
ample of a country where those who certify cause of death
are conservative in their approach, and may adhere to the
formal criteria for MI more strongly than in many other
countries. In contrast, Norway may have a more relaxed
approach to applying these criteria, which would explain
the very high proportion of deaths assigned to MI and the
very weak effect of the place of death or having an autopsy
on the likelihood of certifying an MI. In other words,
Russia is likely to have a low percentage of false-positive
cases but could have a higher percentage of false-negative
cases (deaths out of hospital). Norway might have a high
percentage of false-positive cases (deaths at home) but a
lower percentage of false-negative cases.
Our analyses provide important insights into the inter-
national comparability of MI mortality rates. At the
extremes examined (Russia vs Norway), it appears that dif-
ferences in rates are likely to be strongly influenced by dif-
ferences in the minimal indications required for certifying
a death as being due to an MI. Further work should be
done in Russia and Norway to further test our conclusions
and to investigate this issue in other countries through par-
allel analyses of micro-level data taking account of the
place of death and whether an autopsy was conducted.
Analysis of MI mortality trends within individual countries
should take account of any changes that there may have
been in the proportion of people with a suspected MI who
are hospitalized, as this may impact certification rates.
More broadly, our analyses lead us to question how far
the considerable efforts of expert groups in developing for-
mal criteria for determining whether a death could be de-
termined as due to an MI have so far resulted in data that
are meaningfully comparable across countries, consistently
with previous work questioning the usefulness and validity
of MI determined on the basis of death-certificate mentions
alone. Given that, in all countries, only a proportion of
deaths occur in hospital, the scope for being able to more
accurately identify all deaths as being due to an MI appears
to be limited.
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